Overview

Overlapping Buprenorphine Initiation (in Opioid Physical Dependence)

Status:
Not yet recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
This clinical trial aims to assess the tolerability and effectiveness of overlapping buprenorphine initiation and full agonist opioid discontinuation among patients on high-dose long-term full agonist opioid therapy who have opioid physical dependence.
Phase:
Phase 4
Details
Lead Sponsor:
VA Connecticut Healthcare System
Treatments:
Analgesics, Opioid
Buprenorphine